Proof of Concept Study of an Aspheric Optic Phakic Implantable Collamer Lens (ICL)
| Registry | NCT07791381 |
|---|
| Status | Not yet recruiting |
|---|
| Phase | Not applicable |
|---|
| Study type | Interventional; na, single group, masking: none, treatment |
|---|
| Enrollment | 10 (Estimated) |
|---|
| Sponsor | Staar Surgical Company (Industry) |
|---|
| Conditions | Myopia, Astigmatism |
|---|
| Interventions | Implantable collamer lens (ICL) (Device) |
|---|
| Dates | start 2026-11-01 (estimated), primary completion 2027-05-01 (estimated), completion 2027-05-01 (estimated), first posted 2026-08-27, last updated 2026-08-27 |
|---|
Related Papers Related Patents Related Grants Related Experts
All trials for Myopia All trials for Astigmatism All trials of Implantable collamer lens (ICL)
-Summary
A prospective, open-labeled, single-site study of an implantable collamer lens (ICL) for the correction/reduction of myopia with or without astigmatism.
Expand all sections · Collapse all
+Arms and interventions
| Arm | Type | Interventions | Description |
|---|
| Participants bilaterally implanted with an implantable collamer lens (ICL) | Experimental | Device: Implantable collamer lens (ICL) | Participants will receive an implantable collamer lens (ICL) in each eye |
- Implantable collamer lens (ICL) (Device): ICL with aspheric optic
+Outcome measures
Primary outcomes
- Cumulative and Persistent Adverse Events [3 Months]: Safety Population
Other outcomes
- Rates of Secondary Surgical Interventions [3 Months]: Safety Population
- Frequency and Proportion of eyes with visual symptoms [3 Months]: Safety Population - Visual Symptoms will be captured using a patient reported outcome questionnaire
- The frequency and proportion of eyes with ocular and visual symptoms [3 Months]: Safety Population - Visual Symptoms will be captured using a patient reported outcome questionnaire
- Uncorrected Distance Visual Acuity [3 Months]: Safety Population - Mean Change and Mean Difference
- Uncorrected Intermediate Visual Acuity [3 Months]: Safety Population - Mean Change and Mean Difference
- Uncorrected Near Visual Acuity [3 Months]: Safety Population - Mean Change and Mean Difference
- Best Corrected Distance Visual Acuity [3 Months]: Safety Population - Mean Change and Mean Difference
- Distance Corrected Intermediate Visual Acuity [3 Months]: Safety Population - Mean Change and Mean Difference
- Distance Corrected Near Visual Acuity [3 Months]: Safety Population - Mean Change and Mean Difference
- Mean monocular contrast sensitivity [3 Months]: Safety Population
- Defocus Curves from +1.0 D through -3.0 D defocus [3 Months]: Safety Population
- Subjective Visual Quality [3 Months]: Safety Population - Visual Symptoms will be captured using a patient reported outcome questionnaire
+Eligibility
Sex: All, ages: 21 Years to 60 Years
Inclusion Criteria:
* Must be between the age of 21 - 60 years,
* Must be suitable for ICL surgery,
* Must meet all unique study eligibility criteria
Exclusion Criteria:
* Outside the age of 21 - 60 years,
* Not a suitable candidate for ICL surgery,
* Does not meet all unique study eligibility criteria
+Investigators